6550-- Cancer Diagnosis Probes
ID: 36C26225Q0800Type: Sources Sought
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF262-NETWORK CONTRACT OFFICE 22 (36C262)Gilbert, AZ, 85297, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/26e65c14653c4f72bc473ebdb44798f3/view
Timeline
    Description

    The Department of Veterans Affairs is seeking qualified vendors to provide cancer diagnosis probes for the VA Greater Los Angeles Healthcare System. The procurement focuses on acquiring fluorescent in-situ hybridization probes and reagents necessary for next-generation sequence testing in cytogenetics, specifically equivalent to MetaSystems FISH probes used in diagnosing hematological disorders. This initiative is crucial for maintaining the laboratory's operational capacity and compliance, ensuring efficient testing and reimbursement processes. Interested parties must respond to the Sources Sought Notice by April 21, 2025, and can direct inquiries to Carlos Magana at carlos.magana@va.gov or by phone at 562-766-2253.

    Point(s) of Contact
    Carlos.Magana@va.govCarlos Magana
    (562) 766-2253
    carlos.magana@va.gov
    Files
    Title
    Posted
    36C26225Q0800.docx
    The Department of Veterans Affairs has issued a Sources Sought Notice for cancer diagnosis probes, soliciting interest from potential contractors. The notice outlines important details such as the solicitation number (36C26225Q0800), response deadline (April 21, 2025), contracting office location in Long Beach, California, and performance address at the VA Greater Los Angeles Healthcare System. The relevant product service code is 6550, with a NAICS code of 325413. Key contacts for the inquiry include Carlos Magana, whose email address is provided. Interested parties are directed to view attached documents, including the Statement of Work (SOW) and Request for Information (RFI), to gain further insights into the project requirements. The purpose of this notice is to gather information from market participants to aid in the acquisition process, helping the VA ensure they meet their healthcare needs effectively while promoting supply chain competition. This reflects the VA's strategy to enhance cancer diagnosis capabilities, ultimately improving patient care.
    Attachment A.xlsx
    The document details a Request for Proposals (RFP) from Metasystems, listing various laboratory probes and tests associated with specific identifiers. The file contains a series of items that provide key characteristics and identifiers for several diagnostic products necessary for biomedical research and clinical applications. Each item is sequentially numbered and referenced with a brand name, identification number, and indication to see the Statement of Work (SOW) for additional details. The document requests information on equivalent products, asking for descriptions that match the salient characteristics listed. It also asks for pricing and quantity details, while allocating blank spaces for bidders to provide their company information, such as name, address, telephone number, email, and a point of contact. This solicitation emphasizes the requirement for products that meet specified capabilities, aligned with federal procurement standards. The overall purpose is to gather proposals from qualified vendors capable of providing these specialized probes and testing solutions for government-related biomedical projects.
    RFI.docx
    The Department of Veterans Affairs (VA) is issuing a Request for Information (RFI) to identify potential qualified sources for providing Cytogenetics testing for the VA Los Angeles Healthcare System. This RFI serves informational and planning purposes only, with no contractual obligations for submission. The VA seeks responses from businesses regarding their capabilities, size classifications, and whether they fit specific small business designations such as Service Disabled Veteran Owned, Veteran Owned, or Woman Owned Small Business. Interested parties must supply details about their business status, distribution capabilities, and alignment with the specifications outlined, specifically regarding the availability of "equal to" items. The RFI emphasizes that responders will incur their own costs, and responses must be submitted via email by April 21, 2025. A solicitation announcement may follow the RFI, and all interested parties will need to respond separately to that future solicitation. Additionally, only authorized resellers or distributors of Original Equipment Manufacturer products are acceptable, with strict adherence to OEM standards required for the items proposed.
    SOW.docx
    The Statement of Work (SOW) for the VA Greater Los Angeles Healthcare System outlines the requirements for acquiring fluorescent in-situ hybridization probes and reagents essential for next-generation sequence testing in cytogenetics. Located in a prominent VA facility, the VAGLAHS serves as a reference laboratory within the Desert Pacific Healthcare Network and requires specific validated materials to ensure efficient testing and reimbursement. The SOW specifies the need for reagents that are equivalent to MetaSystems FISH probes used in diagnosing hematological disorders, detailing various required genes and their corresponding products. The procurement process is designed to facilitate an annual purchase order to streamline ordering based on testing demand. Additionally, the document addresses operational hours, security requirements for information systems and contract personnel, emphasizing adherence to federal regulations. Overall, the SOW aims to maintain the laboratory's capacity and compliance through the effective provision of necessary resources.
    Lifecycle
    Title
    Type
    6550-- Cancer Diagnosis Probes
    Currently viewing
    Sources Sought
    Similar Opportunities
    Q301--Biodesix, Inc. (621 II) (PENDING PROPOSAL)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for reference laboratory services under the Federal Supply Schedule (FSS) program, specifically for medical laboratory testing related to the diagnosis, prevention, or treatment of diseases. The procurement aims to establish contracts for domestic delivery of medical laboratory services, ensuring compliance with all relevant state, federal, and local regulations, including necessary licenses and permits for testing services. This opportunity is critical for enhancing patient care through accurate diagnostic testing, with the expectation that offerors will provide new items only, adhering to FDA regulatory requirements. Interested vendors can contact the FSS Help Desk at Fss.Help@va.gov or call 708-786-7737 for further details, as the solicitation is currently pending and specific deadlines for proposal submissions will be outlined in the official solicitation documents.
    Q301--Actionable-554 (LAB) | NEW - Prostate Testing, Urine, Non Invasive
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 19, is conducting a Sources Sought Notice to identify potential suppliers for Non-Invasive Prostate Testing Kits to support the Rocky Mountain Regional VA Medical Center. The procurement aims to acquire a urine-based molecular liquid biopsy test that differentiates between high and low risk of aggressive prostate cancer without using PSA levels or requiring a digital rectal exam (DRE). This testing is crucial for improving patient outcomes by providing accurate risk assessments for prostate cancer, thereby guiding the need for biopsies. Interested vendors must submit their capabilities, including company details and compliance with Federal Acquisition Regulation (FAR) requirements, by December 16, 2025, at 8:00 AM Eastern Time, to Alejandra Sierra at Alejandra.Sierra@va.gov.
    6515--Special Notice -Roche Diagnostic Supplies
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, Network Contracting Office (NCO) 16, intends to issue a sole-source contract to Roche Diagnostic Corporation for the provision of ImmunoHistoChemical (IHC) and compatible Special Stain (SS) Reagents, along with associated services, at the Overton Brooks VA Medical Center (OBVAMC). The contract will span from January 1, 2026, to December 31, 2030, including a base year and four option years, and aims to ensure accurate and efficient diagnostic staining for patient care through the provision of reagents, supplies, maintenance, and 24/7 technical support. This procurement is critical for maintaining high standards in laboratory diagnostics, and interested parties must submit their capabilities statements by December 16, 2025, to Rhonda Gibson at rhonda.gibson2@va.gov, referencing notice number 36C25626Q0248.
    6640--Aerospray Hematology Pro Slide Stainer / Cytocentrifuge
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 16, is seeking proposals from small businesses for the procurement of an Aerospray Hematology Pro Slide Stainer/Cytocentrifuge. This equipment is intended to serve as a backup unit and must meet specific technical specifications, including multipurpose staining capabilities and a high processing rate of slides per hour. The successful offeror will be selected based on the lowest price technically acceptable offer, with key deadlines for questions set for December 10, 2025, and for quotes on December 17, 2025. Interested parties should contact Contract Specialist Angela M. Kennedy at angela.kennedy2@va.gov for further details.
    6640--FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan New Requirement
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure Thyroid Cancer Molecular Tests for the Orlando VA Healthcare System and Caribbean VA Healthcare System through a Firm-Fixed Price (FFP) contract. This procurement is designated as a Service-Disabled Veteran-Owned Small Business (SDVOSBC) set-aside, with the NAICS code 621511 and a small business size standard of $41.5 million. The solicitation is expected to be posted on sam.gov around December 15, 2025, with a response deadline of December 29, 2025, at 4:00 PM Eastern Time. Interested offerors must be registered in the System for Award Management (SAM) to be eligible for award, and for further inquiries, they can contact Yolanda Glover at yolanda.glover@va.gov or by phone at 352-381-5712.
    Distribution of Biorad Bioplex Reagents and Consumables for Laboratory Tests.
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 20, is seeking a qualified contractor for a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract focused on the distribution of BioRad BioPlex reagents and consumables for laboratory tests at the Seattle VA Medical Center. The contractor will be responsible for supplying FDA-approved equipment, reagents, controls, calibrators, and all necessary consumables, along with installation, validation, technical support, preventative maintenance, and staff training, ensuring compliance with specific performance requirements such as rapid analysis and automated calibration. This procurement is critical for enhancing patient care through immunoassays that diagnose various health conditions, including infectious diseases and autoimmune disorders. Quotes are due by December 19, 2025, at 17:00 Pacific Time, and interested parties can contact Hector Gonzalez at hector.gonzalez1@va.gov or by phone at 360-553-7632 for further information.
    Sources Sought - GE Venue Go R4
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contract Office 17, is seeking responses for a Sources Sought Notice regarding the acquisition of a Venue Go R4 Focus Package and associated probes for the Amarillo VA Medical Center's CathLab. This procurement aims to enhance the capabilities of physicians in detecting arterial blockages through the provision of a Venue Ultrasound Unit, which will include all necessary system components for echocardiographs and interventional studies, adhering to relevant guidelines during installation. Interested parties must submit their responses by December 16, 2025, at 10:00 AM CT, including essential business information and an authorization letter from GE Precision Healthcare Ultrasound Systems, with inquiries directed to Rafael Rodriguez at Rafael.Rodriguez2@va.gov or (254) 560-0262.
    Q301--NEW - NTX Combined Reference Lab Testing (Anatomic, Surgical, Genetic) IDIQ
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the NTX Combined Reference Lab Testing (Anatomic, Surgical, Genetic) IDIQ, aimed at providing laboratory testing services for the VA North Texas Healthcare System in Dallas, Texas. The contract will cover a range of services including tissue biopsies, surgical pathology, flow cytometry, and genetic analyses, with a performance period from April 1, 2026, to March 31, 2031, and four option years. This procurement is crucial for ensuring timely and accurate medical testing for veterans, with specific requirements including CLIA accreditation, HIPAA compliance, and secure electronic reporting. Interested vendors must submit their proposals by December 15, 2025, at 3:00 PM Eastern Time, and can direct inquiries to Contracting Officer Delphia Schoenfeld at delphia.schoenfeld@va.gov.
    6505--Pylarify 2026 (VA-26-00025867) RFI
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified sources to provide F18 PSMA Pylarify, a radiopharmaceutical used for positron emission tomography (PET) imaging of prostate cancer, to the Baltimore VA Medical Center. The procurement aims to identify contractors capable of manufacturing, preparing, and transporting this specialized radiopharmaceutical in compliance with stringent regulatory standards, including USNRC, DOT, and FDA guidelines. Pylarify is critical for diagnosing prostate cancer by identifying PSMA-positive lesions, thus playing a vital role in patient care. Interested parties must submit their responses, including company information and qualifications, by December 17, 2025, at 10:00 AM EST, to Contract Specialist Michael Jones at michael.jones16@va.gov.
    Q301 Reference Laboratory Testing for VA Portland Health Care System
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to provide Referral Laboratory services for histocompatibility and immunogenetics testing to support the VA Portland Health Care System's transplant program. The selected laboratory must be accredited by the Organ Procurement and Transplantation Network (OPTN) and capable of performing a range of specialized tests, including HLA typing and antibody screening, while adhering to strict regulatory standards and providing 24/7 critical testing services. This contract, which spans from April 1, 2026, to March 31, 2031, is crucial as the VA Portland Health Care System currently lacks the capability to perform these tests in-house. Interested parties must submit their responses by December 26, 2025, to Eric Lingenfelter at eric.lingenfelter@va.gov, with no funding amount specified at this stage.